Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2016, Article ID 8734309, 8 pages
http://dx.doi.org/10.1155/2016/8734309
Research Article

Nonlethal Levels of Zeaxanthin Inhibit Cell Migration, Invasion, and Secretion of MMP-2 via NF-κB Pathway in Cultured Human Uveal Melanoma Cells

1Department of Ophthalmology, The First Hospital of Jilin University, Changchun 130021, China
2Tissue Culture Center, The New York Eye and Ear Infirmary of Mount Sinai, New York, NY 10003, USA
3Fordham University, New York, NY 10023, USA
4Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China
5Lixiang Eye Hospital of Soochow University, Suzhou 215021, China

Received 27 October 2015; Accepted 4 January 2016

Academic Editor: Shun-Fa Yang

Copyright © 2016 Ming-Chao Bi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D.-N. Hu, G.-P. Yu, S. A. McCormick, S. Schneider, and P. T. Finger, “Population-based incidence of uveal melanoma in various races and ethnic groups,” The American Journal of Ophthalmology, vol. 140, no. 4, pp. 612.e1–617.e8, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. J. J. Augsburger, Z. M. Corrêa, and A. H. Shaikh, “Effectiveness of treatments for metastatic uveal melanoma,” American Journal of Ophthalmology, vol. 148, no. 1, pp. 119–127, 2009. View at Publisher · View at Google Scholar
  3. E. Kujala, T. Mäkitie, and T. Kivelä, “Very long-term prognosis of patients with malignant uveal melanoma,” Investigative Ophthalmology and Visual Science, vol. 44, no. 11, pp. 4651–4659, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Egeblad and Z. Werb, “New functions for the matrix metalloproteinases in cancer progression,” Nature Reviews Cancer, vol. 2, no. 3, pp. 161–174, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. L. M. Coussens, B. Fingleton, and L. M. Matrisian, “Matrix metalloproteinase inhibitors and cancer: trials and tribulations,” Science, vol. 295, no. 5564, pp. 2387–2392, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. A. F. Chambers and L. M. Matrisian, “Changing views of the role of matrix metalloproteinases in metastasis,” Journal of the National Cancer Institute, vol. 89, no. 17, pp. 1260–1270, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Papadopoulou, A. Scorilas, N. Arnogianaki et al., “Expression of gelatinase-A (MMP-2) in human colon cancer and normal colon mucosa,” Tumor Biology, vol. 22, no. 6, pp. 383–389, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Ogasawara, H. Yano, S. Momosaki et al., “Expression of matrix metalloproteinases (MMPs) in cultured hepatocellular carcinoma (HCC) cells and surgically resected HCC tissues,” Oncology Reports, vol. 13, no. 6, pp. 1043–1048, 2005. View at Google Scholar · View at Scopus
  9. B. Schmalfeldt, D. Prechtel, K. Härting et al., “Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer,” Clinical Cancer Research, vol. 7, no. 8, pp. 2396–2404, 2001. View at Google Scholar · View at Scopus
  10. U. B. Hofmann, J. R. Westphal, A. J. W. Zendman, J. C. Becker, D. J. Ruiter, and G. N. P. Van Muijen, “Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type I matrix metalloproteinase (MTI-MMP) correlate with melanoma progression,” Journal of Pathology, vol. 191, no. 3, pp. 245–256, 2000. View at Google Scholar · View at Scopus
  11. S. S. Ahmed, M. N. Lott, and D. M. Marcus, “The macular xanthophylls,” Survey of Ophthalmology, vol. 50, no. 2, pp. 183–193, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. A. J. Whitehead, J. A. Mares, and R. P. Danis, “Macular pigment: a review of current knowledge,” Archives of Ophthalmology, vol. 124, no. 7, pp. 1038–1045, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Kijlstra, Y. Tian, E. R. Kelly, and T. T. J. M. Berendschot, “Lutein: more than just a filter for blue light,” Progress in Retinal and Eye Research, vol. 31, no. 4, pp. 303–315, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. M.-C. Bi, R. Rosen, R.-Y. Zha, S. A. McCormick, E. Song, and D.-N. Hu, “Zeaxanthin induces apoptosis in human uveal melanoma cells through Bcl-2 family proteins and intrinsic apoptosis pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 205082, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Molnár, N. Gyémánt, I. Mucsi et al., “Modulation of multidrug resistance and apoptosis of cancer cells by selected carotenoids,” In Vivo, vol. 18, no. 2, pp. 237–244, 2004. View at Google Scholar · View at Scopus
  16. M. Maccarrone, M. Bari, V. Gasperi, and B. Demmig-Adams, “The photoreceptor protector zeaxanthin induces cell death in neuroblastoma cells,” Anticancer Research, vol. 25, no. 6, pp. 3871–3876, 2005. View at Google Scholar · View at Scopus
  17. K. H. Cha, S. Y. Koo, and D.-U. Lee, “Antiproliferative effects of carotenoids extracted from Chlorella ellipsoidea and Chlorella vulgaris on human colon cancer cells,” Journal of Agricultural and Food Chemistry, vol. 56, no. 22, pp. 10521–10526, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. Z. Li, Y. Wang, and B. Mo, “The effects of carotenoids on the proliferation of human breast cancer cell and gene expression of bcl-2,” Zhonghua Yu Fang Yi Xue Za Zhi, vol. 36, no. 4, pp. 254–257, 2002. View at Google Scholar · View at Scopus
  19. C.-W. Chang, Y.-H. Hsieh, W.-E. Yang, S.-F. Yang, Y. Chen, and D.-N. Hu, “Epigallocatechingallate inhibits migration of human uveal melanoma cells via downregulation of matrix metalloproteinase-2 activity and ERK1/2 pathway,” BioMed Research International, vol. 2014, Article ID 141582, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. B. C. Ji, Y. P. Hsiao, C. H. Tsai et al., “Cantharidin impairs cell migration and invasion of A375.S2 human melanoma cells by suppressing MMP-2 and -9 through PI3k/NF-κB signaling pathways,” Anticancer Research, vol. 35, no. 2, pp. 729–738, 2015. View at Google Scholar
  21. D.-N. Hu, M. Chen, D. Y. Zhang, F. Ye, S. A. McCormick, and C.-C. Chan, “Interleukin-1β increases baseline expression and secretion of interleukin-6 by human uveal melanocytes in vitro via the p38 MAPK/NF-κB pathway,” Investigative Ophthalmology and Visual Science, vol. 52, no. 6, pp. 3767–3774, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. S.-C. Chu, D.-N. Hu, S.-F. Yang et al., “Uveal melanocytes produce matrix metalloproteinases-2 and -9 in vitro,” Pigment Cell Research, vol. 17, no. 6, pp. 636–642, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. El-Shabrawi, N. Ardjomand, H. Radner, and N. Ardjomand, “MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma,” Journal of Pathology, vol. 194, no. 2, pp. 201–206, 2001. View at Google Scholar · View at Scopus
  24. A. Väisänen, M. Kallioinen, K. Von Dickhoff, L. Laatikainen, M. Höyhtyä, and T. Turpeenniemi-Hujanen, “Matrix metalloproteinase-2 (MMP-2) immunoreactive protein—a new prognostic marker in uveal melanoma?” Journal of Pathology, vol. 188, no. 1, pp. 56–62, 1999. View at Google Scholar · View at Scopus
  25. G. A. Alyahya, M. Kolko, J. U. Prause, B. S. Nielsen, J. Wang, and S. Heegaard, “Matrix metalloproteinase-2 is expressed in melanoma-associated spongiform scleropathy,” Investigative Ophthalmology and Visual Science, vol. 49, no. 7, pp. 2806–2811, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Lai, R. M. Conway, R. Crouch, M. J. Jager, and M. C. Madigan, “Expression and distribution of MMPs and TIMPs in human uveal melanoma,” Experimental Eye Research, vol. 86, no. 6, pp. 936–941, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Béliveau, M. Bérubé, A. Rousseau, G. Pelletier, and S. L. Guérin, “Expression of integrin α5β1 and MMPs associated with epithelioid morphology and malignancy of uveal melanoma,” Investigative Ophthalmology and Visual Science, vol. 41, no. 8, pp. 2363–2372, 2000. View at Google Scholar · View at Scopus
  28. J. K. L. Baker, S. R. Elshaw, G. E. L. Mathewman et al., “Expression of integrins, degradative enzymes and their inhibitors in uveal melanoma: differences between in vitro and in vivo expression,” Melanoma Research, vol. 11, no. 3, pp. 265–273, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Bérubé, A. Deschambeault, M. Boucher, L. Germain, E. Petitclerc, and S. L. Guérin, “MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment,” Molecular Vision, vol. 11, pp. 1101–1111, 2005. View at Google Scholar · View at Scopus
  30. P. Elumalai, A. Brindha Mercy, R. Arunkamar et al., “Nimbolide inhibits invasion and migration, and down-regulates uPAR chemokine gene expression, in two breast cancer cell lines,” Cell Proliferation, vol. 47, no. 6, pp. 540–552, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Kumar, Y. Takada, A. M. Boriek, and B. B. Aggarwal, “Nuclear factor-κB: its role in health and disease,” Journal of Molecular Medicine, vol. 82, no. 7, pp. 434–448, 2004. View at Google Scholar · View at Scopus
  32. S. Hu, Q. Luo, B. Cun et al., “The pharmacological NF-κB inhibitor BAY11-7082 induces cell apoptosis and inhibits the migration of human uveal melanoma cells,” International Journal of Molecular Sciences, vol. 13, no. 12, pp. 15653–15667, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Meir, R. Dror, X. Yu et al., “Molecular characteristics of liver metastases from uveal melanoma,” Investigative Ophthalmology and Visual Science, vol. 48, no. 11, pp. 4890–4896, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Dror, M. Lederman, K. Umezawa, V. Barak, J. Pe'er, and I. Chowers, “Characterizing the involvement of the nuclear factor-kappa B (NF kappa B) transcription factor in uveal melanoma,” Investigative Ophthalmology & Visual Science, vol. 51, no. 4, pp. 1811–1816, 2010. View at Google Scholar
  35. N. Liu, Q. Sun, J. Chen et al., “MicroRNA-9 suppresses uveal melanoma cell migration and invasion through the NF-κB1 pathway,” Oncology Reports, vol. 28, no. 3, pp. 961–968, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. C.-S. Shia, G. Suresh, Y.-C. Hou, Y.-C. Lin, P.-D. L. Chao, and S.-H. Juang, “Suppression on metastasis by rhubarb through modulation on MMP-2 and uPA in human A549 lung adenocarcinoma: an ex vivo approach,” Journal of Ethnopharmacology, vol. 133, no. 2, pp. 426–433, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. P. K. Vayalil and S. K. Katiyar, “Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-κB in human prostate carcinoma DU-145 cells,” Prostate, vol. 59, no. 1, pp. 33–42, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. X. L. Xu, D.-N. Hu, C. Iacob et al., “Effects of zeaxanthin on growth and invasion of human uveal melanoma in nude mouse model,” Journal of Ophthalmology, vol. 2015, Article ID 392305, 8 pages, 2015. View at Publisher · View at Google Scholar
  39. N.-L. Wu, Y.-C. Chiang, C.-C. Huang, J.-Y. Fang, D.-F. Chen, and C.-F. Hung, “Zeaxanthin inhibits PDGF-BB-induced migration in human dermal fibroblasts,” Experimental Dermatology, vol. 19, no. 8, pp. e173–e181, 2010. View at Publisher · View at Google Scholar · View at Scopus